Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 7 studies | 60% ± 23% | |
adipocyte | 4 studies | 19% ± 1% | |
astrocyte | 4 studies | 32% ± 9% | |
GABAergic neuron | 3 studies | 21% ± 4% | |
glutamatergic neuron | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 91% | 666.06 | 163 / 180 | 90% | 6.84 | 389 / 430 |
adrenal gland | 100% | 2256.84 | 258 / 258 | 57% | 18.26 | 130 / 230 |
brain | 53% | 354.13 | 1399 / 2642 | 83% | 3.95 | 584 / 705 |
kidney | 92% | 878.67 | 82 / 89 | 40% | 17.25 | 364 / 901 |
stomach | 83% | 827.23 | 297 / 359 | 45% | 15.12 | 129 / 286 |
prostate | 43% | 323.67 | 106 / 245 | 80% | 5.19 | 404 / 502 |
thymus | 36% | 242.74 | 237 / 653 | 77% | 8.64 | 468 / 605 |
eye | 0% | 0 | 0 / 0 | 100% | 25.19 | 80 / 80 |
muscle | 100% | 34110.62 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 39347.93 | 856 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 1513.95 | 1309 / 1335 | 0% | 0 | 0 / 0 |
uterus | 58% | 335.75 | 99 / 170 | 24% | 4.43 | 108 / 459 |
pancreas | 2% | 9.11 | 6 / 328 | 69% | 2.78 | 122 / 178 |
intestine | 10% | 55.05 | 101 / 966 | 49% | 13.88 | 260 / 527 |
breast | 25% | 185.85 | 117 / 459 | 33% | 1.55 | 365 / 1118 |
esophagus | 44% | 332.34 | 632 / 1445 | 14% | 0.64 | 26 / 183 |
bladder | 29% | 151.19 | 6 / 21 | 22% | 5.38 | 109 / 504 |
adipose | 44% | 305.81 | 527 / 1204 | 0% | 0 | 0 / 0 |
skin | 13% | 93.88 | 230 / 1809 | 26% | 4.30 | 124 / 472 |
lung | 3% | 49.35 | 15 / 578 | 19% | 1.18 | 215 / 1155 |
liver | 0% | 0 | 0 / 226 | 19% | 5.24 | 79 / 406 |
tonsil | 0% | 0 | 0 / 0 | 9% | 1.24 | 4 / 45 |
spleen | 2% | 10.20 | 5 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 19.70 | 12 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006936 | Biological process | muscle contraction |
GO_0046314 | Biological process | phosphocreatine biosynthetic process |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0004111 | Molecular function | creatine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | CKMT2 |
Protein name | Creatine kinase, mitochondrial 2 Creatine kinase S-type, mitochondrial (EC 2.7.3.2) (Basic-type mitochondrial creatine kinase) (Mib-CK) (Sarcomeric mitochondrial creatine kinase) (S-MtCK) |
Synonyms | |
Description | FUNCTION: Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa. |
Accessions | D6R998 ENST00000254035.9 D6RHV3 ENST00000511719.5 ENST00000424301.6 P17540 ENST00000505060.1 ENST00000437669.5 |